8 results match your criteria: "1 Institute of Experimental Medicine[Affiliation]"
Benef Microbes
December 2018
1 Institute of Experimental Medicine, 12 Academician Pavlov str., Saint-Petersburg, 197376, Russia.
The biological effects of three probiotic strains K32, GT15, L3 and their mixture were studied using a model of dysbiosis induced in rats by antibiotics. It was found that after taking different probiotics intestinal microbiota changed in a strain-specific manner. The maximal activity against pathogens was revealed after the administration of a mixture of bacterial strains under study or a single strain of enterococci.
View Article and Find Full Text PDFTissue Eng Part C Methods
June 2017
1 Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic .
Extracellular matrix (ECM) hydrogels prepared by tissue decellularization have been reported as natural injectable materials suitable for neural tissue repair. In this study, we prepared ECM hydrogel derived from human umbilical cord (UC) and evaluated its composition and mechanical and biological properties in comparison with the previously described ECM hydrogels derived from porcine urinary bladder (UB), brain, and spinal cord. The ECM hydrogels did not differ from each other in the concentration of collagen, while the highest content of glycosaminoglycans as well as the shortest gelation time was found for UC-ECM.
View Article and Find Full Text PDFBenef Microbes
November 2016
1 Institute of Experimental Medicine, 12 Academician Pavlov St., 197376 St.-Petersburg, Russian Federation.
Tissue Eng Part A
February 2016
1 Institute of Experimental Medicine AS CR, Prague, Czech Republic .
Restoration of lost neuronal function after spinal cord injury (SCI) still remains a big challenge for current medicine. One important repair strategy is bridging the SCI lesion with a supportive and stimulatory milieu that would enable axonal rewiring. Injectable extracellular matrix (ECM)-derived hydrogels have been recently reported to have neurotrophic potential in vitro.
View Article and Find Full Text PDFExpert Opin Biol Ther
September 2016
b 2 Institute of Experimental Medicine ASCR, Department of Neuroscience , Prague, Czech Republic.
Introduction: Stroke is one of the most devastating diseases and a leading cause of mortality worldwide. So far, clinical management of stroke involves surgical clot retrieval or thrombolytic treatment inducing reperfusion of the occluded vessels in the cerebral infarcted area, which is dependent on early intervention following insult. New treatment strategies involve the promotion of angiogenesis and neuroplasticity, stimulation of endogenous neurogenesis, remyelinization, and immunomodulation by means of cell transplantation and sustained drug delivery.
View Article and Find Full Text PDFStem Cells Dev
October 2014
1 Institute of Experimental Medicine, Academy of Sciences of the Czech Republic , Prague, Czech Republic .
The aim of this study was to investigate the effects of systemically administered bone-marrow-derived mesenchymal stromal cells (MSCs) on the early acute phase of inflammation in the alkali-burned eye. Mice with damaged eyes were either untreated or treated 24 h after the injury with an intravenous administration of fluorescent-dye-labeled MSCs that were unstimulated or pretreated with interleukin-1α (IL-1α), transforming growth factor-β (TGF-β), or interferon-γ (IFN-γ). Analysis of cell suspensions prepared from the eyes of treated mice on day 3 after the alkali burn revealed that MSCs specifically migrated to the damaged eye and that the number of labeled MSCs was more than 30-times higher in damaged eyes compared with control eyes.
View Article and Find Full Text PDFLeukemia
March 2014
1] Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Prague, Czech Republic [2] Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University, Prague, Czech Republic.
Stem Cells Dev
October 2013
1 Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary .
Retinoic acid (RA) is present at sites of neurogenesis in both the embryonic and adult brain. While it is widely accepted that RA signaling is involved in the regulation of neural stem cell differentiation, little is known about vitamin A utilization and biosynthesis of active retinoids in the neurogenic niches, or about the details of retinoid metabolism in neural stem cells and differentiating progenies. Here we provide data on retinoid responsiveness and RA production of distinct neural stem cell/neural progenitor populations.
View Article and Find Full Text PDF